Evolution of targeted therapies in cancer: opportunities and challenges in the clinic
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evolution of targeted therapies in cancer: opportunities and challenges in the clinic
Authors
Keywords
-
Journal
Future Oncology
Volume 11, Issue 2, Pages 279-293
Publisher
Future Medicine Ltd
Online
2015-01-16
DOI
10.2217/fon.14.198
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer
- (2014) Christian Rolfo et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- C11orf95–RELA fusions drive oncogenic NF-κB signalling in ependymoma
- (2014) Matthew Parker et al. NATURE
- Oncogenic ERBB3 Mutations in Human Cancers
- (2013) Bijay S. Jaiswal et al. CANCER CELL
- ALK Rearrangements Are Mutually Exclusive with Mutations in EGFR or KRAS: An Analysis of 1,683 Patients with Non-Small Cell Lung Cancer
- (2013) J. F. Gainor et al. CLINICAL CANCER RESEARCH
- Pertuzumab: Optimizing HER2 Blockade
- (2013) O. Metzger-Filho et al. CLINICAL CANCER RESEARCH
- Targeting c-MET in the battle against advanced nonsmall-cell lung cancer
- (2013) Lorenza Landi et al. CURRENT OPINION IN ONCOLOGY
- Pertuzumab: A Review of Its Use for First-Line Combination Treatment of HER2-Positive Metastatic Breast Cancer
- (2013) Paul L. McCormack DRUGS
- Dacomitinib, a new therapy for the treatment of non-small cell lung cancer
- (2013) Christina Brzezniak et al. EXPERT OPINION ON PHARMACOTHERAPY
- Oncogene and non-oncogene addiction in inflammation-associated cancers
- (2013) Min Zheng et al. Future Oncology
- Skin toxicity of targeted cancer agents: mechanisms and intervention
- (2013) Viswanath Reddy Belum et al. Future Oncology
- Tumour heterogeneity and cancer cell plasticity
- (2013) Corbin E. Meacham et al. NATURE
- The causes and consequences of genetic heterogeneity in cancer evolution
- (2013) Rebecca A. Burrell et al. NATURE
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- The quest to overcome resistance to EGFR-targeted therapies in cancer
- (2013) Curtis R Chong et al. NATURE MEDICINE
- Tumor adaptation and resistance to RAF inhibitors
- (2013) Piro Lito et al. NATURE MEDICINE
- Implementing personalized cancer genomics in clinical trials
- (2013) Richard Simon et al. NATURE REVIEWS DRUG DISCOVERY
- Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer
- (2013) Christoph Plass et al. NATURE REVIEWS GENETICS
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Bypass Mechanisms of Resistance to Receptor Tyrosine Kinase Inhibition in Lung Cancer
- (2013) M. J. Niederst et al. Science Signaling
- Skinflammation and Drug Toxicity--A Delicate Balance
- (2013) M. E. Lacouture et al. Science Translational Medicine
- Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer
- (2013) Alberto Bardelli et al. Cancer Discovery
- How Molecular Understanding Affects to Prescribing Patterns and Clinical Outcome of Gefitinib in Non-small Cell Lung Cancer? 10 Year Experience of Single Institution
- (2013) Bhumsuk Keam et al. Cancer Research and Treatment
- Rare Though Not Mutually Exclusive: A Report of Three Cases of Concomitant KRAS and BRAF Mutation and a Review of the Literature
- (2013) Ibrahim Halil Sahin et al. Journal of Cancer
- A view on EGFR-targeted therapies from the oncogene-addiction perspective
- (2013) Rolando Perez et al. Frontiers in Pharmacology
- Genetic Basis of Pancreas Cancer Development and Progression: Insights from Whole-Exome and Whole-Genome Sequencing
- (2012) C. A. Iacobuzio-Donahue et al. CLINICAL CANCER RESEARCH
- Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents
- (2012) M. Mao et al. CLINICAL CANCER RESEARCH
- Biologics against cancer-specific receptors – challenges to personalised medicine from early trial results
- (2012) Samer-ul Haque et al. CURRENT OPINION IN PHARMACOLOGY
- The battle against ALK resistance: successes and setbacks
- (2012) Claudia Voena et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Mechanisms of acquired resistance to targeted cancer therapies
- (2012) Mark R Lackner et al. Future Oncology
- Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3
- (2012) C. F. McDonagh et al. MOLECULAR CANCER THERAPEUTICS
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
- (2012) Anirudh Prahallad et al. NATURE
- Recurrent R-spondin fusions in colon cancer
- (2012) Somasekar Seshagiri et al. NATURE
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
- (2012) Timothy R. Wilson et al. NATURE
- Overcoming implementation challenges of personalized cancer therapy
- (2012) Funda Meric-Bernstam et al. Nature Reviews Clinical Oncology
- MET: a promising anticancer therapeutic target
- (2012) Solange Peters et al. Nature Reviews Clinical Oncology
- Two Hundred Years of Cancer Research
- (2012) Vincent T. DeVita et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
- (2012) Ryan B. Corcoran et al. Cancer Discovery
- Noncovalent Wild-type–Sparing Inhibitors of EGFR T790M
- (2012) Ho-June Lee et al. Cancer Discovery
- A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT
- (2011) J L Bryant et al. BRITISH JOURNAL OF CANCER
- Antitumor Activity of BRAF Inhibitor Vemurafenib in Preclinical Models of BRAF-Mutant Colorectal Cancer
- (2011) H. Yang et al. CANCER RESEARCH
- EGFR-mutated oncogene-addicted non-small cell lung cancer: Current trends and future prospects
- (2011) Jean-Charles Soria et al. CANCER TREATMENT REVIEWS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- New Strategies for Treatment of ALK-Rearranged Non-Small Cell Lung Cancers
- (2011) T. Sasaki et al. CLINICAL CANCER RESEARCH
- Effectiveness of Tyrosine Kinase Inhibitors on "Uncommon" Epidermal Growth Factor Receptor Mutations of Unknown Clinical Significance in Non-Small Cell Lung Cancer
- (2011) J.-Y. Wu et al. CLINICAL CANCER RESEARCH
- Tyrosine kinase gene fusions in cancer: translating mechanisms into targeted therapies
- (2011) Sandrine Medves et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- BRAFV600E: Implications for Carcinogenesis and Molecular Therapy
- (2011) E. R. Cantwell-Dorris et al. MOLECULAR CANCER THERAPEUTICS
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
- (2011) Poulikos I. Poulikakos et al. NATURE
- Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression
- (2011) Mina J Bissell et al. NATURE MEDICINE
- Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer
- (2011) Dan R Robinson et al. NATURE MEDICINE
- Targeting the human EGFR family in esophagogastric cancer
- (2011) Alicia Okines et al. Nature Reviews Clinical Oncology
- Personalized medicine in lung cancer: what we need to know
- (2011) Tony S. K. Mok Nature Reviews Clinical Oncology
- Treatment of HER2-positive breast cancer: current status and future perspectives
- (2011) Carlos L. Arteaga et al. Nature Reviews Clinical Oncology
- The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma
- (2011) Nardin Samuel et al. Nature Reviews Gastroenterology & Hepatology
- Adjuvant Trastuzumab in HER2-Positive Breast Cancer
- (2011) Dennis Slamon et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Perspective on Cancer Cell Metastasis
- (2011) C. L. Chaffer et al. SCIENCE
- Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
- (2011) L. V. Sequist et al. Science Translational Medicine
- Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
- (2010) Alexa B. Turke et al. CANCER CELL
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- Evolving Strategies for Overcoming Resistance to HER2-Directed Therapy: Targeting the PI3K/Akt/mTOR Pathway
- (2010) Rita Nahta et al. Clinical Breast Cancer
- The biology and treatment of EML4-ALK non-small cell lung cancer
- (2010) Takaaki Sasaki et al. EUROPEAN JOURNAL OF CANCER
- Good Clinical Response to Gefitinib in a Non-small Cell Lung Cancer Patient Harboring a Rare Somatic Epidermal Growth Factor Gene Point Mutation; Codon 768 AGC > ATC in Exon 20 (S768I)
- (2010) K. Masago et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Clinical Experience With Hedgehog Pathway Inhibitors
- (2010) Jennifer A. Low et al. JOURNAL OF CLINICAL ONCOLOGY
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeted Cancer Therapeutics
- (2009) William N. Hait CANCER RESEARCH
- Cancer Prevention: From 1727 to Milestones of the Past 100 Years
- (2009) Scott M. Lippman et al. CANCER RESEARCH
- Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer
- (2009) David Jackman et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
- (2009) Wenjun Zhou et al. NATURE
- Molecular predictors of response to trastuzumab and lapatinib in breast cancer
- (2009) Francisco J. Esteva et al. Nature Reviews Clinical Oncology
- Implications for KRAS status and EGFR-targeted therapies in metastatic CRC
- (2009) Nicola Normanno et al. Nature Reviews Clinical Oncology
- Molecular Basis of Colorectal Cancer
- (2009) Sanford D. Markowitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma
- (2009) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- A History of Cancer Chemotherapy
- (2008) Vincent T. DeVita et al. CANCER RESEARCH
- Oncogene Addiction
- (2008) I. B. Weinstein et al. CANCER RESEARCH
- Recent Advances in Head and Neck Cancer
- (2008) Robert I. Haddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tamoxifen: Catalyst for the change to targeted therapy
- (2007) V. Craig Jordan EUROPEAN JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now